FAVORITO, VALENTINA
 Distribuzione geografica
Continente #
AS - Asia 534
NA - Nord America 269
EU - Europa 238
SA - Sud America 25
AF - Africa 13
Totale 1.079
Nazione #
US - Stati Uniti d'America 261
VN - Vietnam 205
IT - Italia 133
CN - Cina 119
SG - Singapore 114
HK - Hong Kong 36
NL - Olanda 30
BR - Brasile 20
IN - India 18
DE - Germania 15
FR - Francia 14
KR - Corea 12
FI - Finlandia 11
GB - Regno Unito 9
CH - Svizzera 5
IQ - Iraq 5
PH - Filippine 5
BD - Bangladesh 4
JP - Giappone 4
MX - Messico 4
RU - Federazione Russa 4
TH - Thailandia 4
AR - Argentina 3
CA - Canada 3
DZ - Algeria 3
ES - Italia 3
PL - Polonia 3
BE - Belgio 2
CI - Costa d'Avorio 2
KE - Kenya 2
SA - Arabia Saudita 2
SC - Seychelles 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
BA - Bosnia-Erzegovina 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
GR - Grecia 1
IE - Irlanda 1
IL - Israele 1
JO - Giordania 1
KZ - Kazakistan 1
LT - Lituania 1
MD - Moldavia 1
ML - Mali 1
PE - Perù 1
PR - Porto Rico 1
SE - Svezia 1
TN - Tunisia 1
TW - Taiwan 1
UA - Ucraina 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 1.079
Città #
Singapore 79
Ho Chi Minh City 51
Hanoi 49
Ashburn 46
Dallas 35
Hong Kong 35
Hefei 33
Bologna 29
San Jose 26
New York 25
Santa Clara 17
Milan 14
Beijing 12
Seoul 10
Los Angeles 9
Boardman 8
Council Bluffs 8
Haiphong 8
Buffalo 6
Da Nang 6
Helsinki 6
Modena 6
Munich 6
The Dalles 6
Mumbai 5
Visakhapatnam 5
Amsterdam 4
Frankfurt am Main 4
Ha Long 4
Pescara 4
Poplar 4
Tokyo 4
Algiers 3
Bengaluru 3
Biên Hòa 3
Bắc Giang 3
Bắc Ninh 3
Changsha 3
Grosseto 3
Hải Dương 3
Luco dei Marsi 3
Quận Một 3
Quận Phú Nhuận 3
Redondo Beach 3
San Francisco 3
Shanghai 3
Turku 3
Warsaw 3
Abidjan 2
Atlanta 2
Bari 2
Brussels 2
Can Tho 2
Catania 2
Chennai 2
Chongqing 2
Denver 2
Falkenstein 2
Guangzhou 2
Lauterbourg 2
Mexico City 2
Montreal 2
Moscow 2
Nanyang 2
Nha Trang 2
Ninh Bình 2
Novara 2
Orem 2
Paris 2
Philadelphia 2
Phoenix 2
Qingdao 2
Quảng Ngãi 2
Quảng Ninh 2
Quận Bình Thạnh 2
Rimini 2
Rio de Janeiro 2
Rome 2
Salerno 2
Taurianova 2
Terni 2
Turin 2
Tân An 2
Vinh 2
Zurich 2
Almenno San Bartolomeo 1
Amparo 1
Austin 1
Baden 1
Baghdad 1
Bamako 1
Bang Lamung 1
Bang Phli 1
Barbacena 1
Barcelona 1
Bexley 1
Boston 1
Botticino 1
Boydton 1
Brejo 1
Totale 701
Nome #
STK11 mutations correlate with poor prognosis for advanced NSCLC treated with first-line immunotherapy or chemo-immunotherapy according to KRAS, TP53, KEAP1, and SMARCA4 status 234
Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRASG12C inhibitors 187
Development and validation of a new tool to estimate early mortality in patients with advanced cancer treated with immunotherapy 157
Early monitoring of plasma KRAS G12C with digital PCR predicts antitumor response to immunotherapy or sotorasib in advanced NSCLC: A brief report 125
Resistance to KRAS G12C Inhibition in Non-small Cell Lung Cancer 108
First-Generation Epidermal Growth Factor Receptor Inhibitors Plus Antiangiogenic Drugs Versus Third-Generation Epidermal Growth Factor Receptor Inhibitors in Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis 91
Non-small cell lung cancer: an update on emerging EGFR-targeted therapies 84
Efficacy and Safety of TROP-2-Targeting Antibody–Drug Conjugate Treatment in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer: A Systematic Review and Pooled Analysis of Reconstructed Patient Data 60
Immunotherapy beyond progression combined with platinum-based chemotherapy after primary resistance to first-line immunotherapy in patients with advanced NSCLC and PD-L1 ≥50% 39
Immunogenicity of two doses of BNT162b2 and mRNA‐1273 vaccines for solid cancer patients on treatment with or without a previous SARS‐CoV‐2 infection 21
Totale 1.106
Categoria #
all - tutte 2.187
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.187


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20247 0 0 0 0 0 0 0 1 2 0 0 4
2024/2025261 1 8 5 18 26 12 25 19 6 41 31 69
2025/2026838 141 73 64 70 37 62 55 33 158 88 57 0
Totale 1.106